A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Sponsor: Merck Sharp & Dohme LLC
Lexington, KY · +62 more sites
10 recruiting prostate cancer studies with a site in Lexington, KY.
Sponsor: Merck Sharp & Dohme LLC
Lexington, KY · +62 more sites
Sponsor: National Cancer Institute (NCI)
Lexington, KY · +12 more sites
Sponsor: SWOG Cancer Research Network
Lexington, KY · +331 more sites
Sponsor: Alliance for Clinical Trials in Oncology
Bardstown, KY · Corbin, KY · Edgewood, KY · +744 more sites
Sponsor: ECOG-ACRIN Cancer Research Group
Lexington, KY · +338 more sites
Sponsor: University of Kentucky
Lexington, KY
Sponsor: Canadian Cancer Trials Group
Bardstown, KY · Corbin, KY · Lexington, KY · +371 more sites
Sponsor: Orano Med Theranostics, SAS
Lexington, KY · +7 more sites
Sponsor: Clasp Therapeutics, Inc.
Lexington, KY · +20 more sites
Sponsor: SWOG Cancer Research Network
Bardstown, KY · Corbin, KY · Lexington, KY · +130 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.